Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
13 results
- 2/3상모집 중· HER2-positive Breast Cancer국소진행성 또는 전이성 HER2 양성 유방암에서 RO7771950과 투카티닙의 효능 및 안전성 비교
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
리드: 로슈
- 2/3상모집 중· Haematological MalignancyDETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
협력: 로슈
- 2/3상모집 중· Membranous Nephropathy - PLA2R InducedObinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study
협력: 로슈
- 2/3상모집 중· Haematological MalignancyDETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
협력: 로슈
- 2/3상모집 중· Haematological MalignancyDETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
협력: 로슈
- 2/3상모집 중단 (진행 중)· Spinal Muscular Atrophy (SMA)A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
리드: 로슈
- 2/3상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
- 2/3상모집 중단 (진행 중)· Colorectal NeoplasmPerioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
협력: 로슈
- 2/3상모집 중단 (진행 중)· Alzheimers DiseaseDominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
협력: 일라이 릴리, 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.
